BIOMERICA INC

In Vitro & In Vivo Diagnostic Substances

BMRA Pharmaceuticals & Biotechnology People in Pharmaceuticals & Biotechnology SEC CIK 0000073290 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$10.28M
3,090,269 shares Covers every share class this company has on file.
Insiders on file
1
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$70.7K
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
0.69%
insider-held value divided by market capitalisation

What BIOMERICA INC reports

Revenue and net income below are for fiscal period FY2026, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$4.45M
FY2026 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
-$3.78M
FY2026 a loss for the period, from this company’s own annual XBRL filings to the SEC
Employees
50
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at BIOMERICA INC

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

People who file insider reports against BIOMERICA INC.
Insider Reported role Shares Value Last action
David Moatazedi Executive 30,625 $70.7K P Open-market purchase Aug 26, 2026 position reported

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

David Moatazedi bought 10,000 BIOMERICA INC (BMRA) shares for $16,000 on Aug 26, 2026

Unusual change in a direct holding

Flagged because the change that day in the shares this person holds directly was unusually large compared with their own earlier changes. The rows below are the open-market trades reported that day; under each share count is the balance the filing reports after that line. At least one price in this event could not be cross-checked against other trades in the same security, so read the total with extra care.

David Moatazedi bought 10,000 BIOMERICA INC (BMRA) shares for $16,000 on Aug 26, 2026
Date Insider Transaction Shares Price Value Filing
Aug 26, 2026 David Moatazedi P Open-market purchase 10,000 held after: 40,625 $1.60 $16,000 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Recent insider transactions

Of the 3 rows we hold, 1 are open-market purchases (P) and 0 open-market sales — the only codes we count as buying or selling.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for BIOMERICA INC, newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Aug 26, 2026 David Moatazedi P Open-market purchase 10,000 $1.60 $16.0K SEC filing ↗
Dec 12, 2025 David Moatazedi A Grant or award 20,000 $0.00 $0 SEC filing ↗
Dec 13, 2024 David Moatazedi A Grant or award 85,000 $0.31 $26.4K SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from BIOMERICA INC’s own filings and multiplied by our closing price. Full method.

What that share count means

the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from BIOMERICA INC’s own SEC filings multiplied by the closing price we hold for the same stock.